Effects of IL-1β Inhibition on Anemia and Clonal Hematopoiesis in the Randomized CANTOS Trial

0
64
Proteogenomic analyses aimed to understand the clinical response to canakinumab and underlying proteomic profiles in the context of clonal hematopoiesis and anemia.
[Blood Advances]
Abstract